Introduction: Although heterogeneity of treatment effects (HTEs) is commonly observed in clinical trials, it has received little attention in studies on transcranial direct current stimulation (tDCS). Objectives: This study identified the presence of HTE in tDCS treatment among participants with symptomatic knee osteoarthritis (KOA) and explored participant characteristics associated with this heterogeneity. Methods: This secondary analysis of a randomized clinical trial included 120 participants with symptomatic KOA who received 15 daily sessions of home-based 2-mA active or sham tDCS over 3 weeks. We used a multitrajectory analysis to identify distinct subgroups based on the longitudinal trajectories of KOA pain and symptoms from baseline to 3 months postintervention, capturing differential responses to tDCS. We then performed bivariate analyses to examine associations between trajectory groups and baseline demographic, clinical, and quantitative sensory testing characteristics. Results: In the active tDCS group, 2 distinct trajectories emerged: “low initial symptoms with significant improvement” (high responders; n 5 28) and “high initial symptoms with minimal improvement” (low responders; n 5 32). Compared to high responders, low responders had a higher body mass index, lower educational attainment, and greater pain catastrophizing (all P , 0.05). Low responders also exhibited lower pressure pain thresholds at both the medial knee and trapezius, higher punctate mechanical pain at both the patella and hand, lower conditioned pain modulation, and higher cold pain intensity at baseline (all P , 0.05). No notable HTE was observed in the sham tDCS group. Conclusion: Participants exhibited varying responses to active tDCS. The characteristics associated with HTE may inform the development of personalized stimulation protocols.
Lee et al. (Wed,) studied this question.